Recent Finacing
Recent Raise
Insamo develops membrane-permeable, orally available cyclic peptides with antibody-like binding affinity using an integrated platform combining ML-driven molecular design, ultra-high-throughput molecular biology, parallel synthetic chemistry, and automated design–synthesis–testing workflows.
